12.4 C
London
Friday, October 7, 2022
- Advertisement -spot_img

CATEGORY

BIIB

Biogen: Alzheimer's Expert Sees 'Plenty of Patient Demand' for Aduhelm

It would be no exaggeration to say last week’s FDA decision to approve Aduhelm - Biogen’s (BIIB) treatment for Alzheimer’s - is a landmark...

Latest news

- Advertisement -spot_img